4 References [1] W. F. Young Jr., “The incidentally discovered adrenal mass,” The New England Journal of Medicine, vol. 356, no. 6, pp. 601– 610, 2007. [2] P. J. Kenney, B. J. Wagner, P. Rao, and C. S. Heﬀess, “Myelolipoma: CT and pathologic features,” Radiology, vol. 208, no. 1, pp. 87–95, 1998. [3] E. Lezoche, M. Guerrieri, F. Crosta, et al., “Perioperative results of 214 laparoscopic adrenalectomies by anterior transperitoneal approach,” Surgical Endoscopy, vol. 22, no. 2, pp. 522–526, 2008. [4] G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, and S. R. Bornstein, “The clinically inapparent adrenal mass: update in diagnosis and management,” Endocrine Reviews, vol. 25, no. 2, pp. 309–340, 2004. [5] P. Rao, P. J. Kenney, B. J. Wagner, and A. J. Davidson, “Imaging and pathologic features of myelolipoma,” Radiographics, vol. 17, no. 6, pp. 1373–1385, 1997. [6] H. Hisamatsu, H. Sakai, S. Tsuda, K. Shigematsu, and H. Kanetake, “Combined adrenal adenoma and myelolipoma in a patient with Cushing’s syndrome: case report and review of the literature,” International Journal of Urology, vol. 11, no. 6, pp. 416–418, 2004. [7] R. Ravichandran, F. Laﬀerty, M. J. McGinniss, and H. C. Taylor, “Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life: report of two patients with 21-hydroxylase deﬁciency,” The Journal of Clinical Endocrinology & Metabolism, vol. 81, no. 5, pp. 1776– 1779, 1996. [8] M. Sakaki, H. Izaki, T. Fukumori, R. Taue, T. Kishimoto, and H.-O. Kanayama, “Bilateral adrenal myelolipoma associated with adrenogenital syndrome,” International Journal of Urol- ogy, vol. 13, no. 6, pp. 801–802, 2006. [9] M. B. Umpierrez, S. Fackler, G. E. Umpierrez, and J. Rubin, “Adrenal myelolipoma associated with endocrine dysfunction: review of the literature,” American Journal of the Medical Sciences, vol. 314, no. 5, pp. 338–341, 1997. [10] K. H. Allison, G. N. Mann, T. H. Norwood, and B. P. Rubin, “An unusual case of multiple giant myelolipomas: clinical and pathogenetic implications,” Endocrine Pathology, vol. 14, no. 1, pp. 93–100, 2003. [11] A. Oliva, B. Duarte, R. Hammadeh, L. Ghosh, and R. J. Baker, “Myelolipoma and endocrine dysfunction,” Surgery, vol. 103, no. 6, pp. 711–715, 1988. [12] S. M. Baumgartner-Parzer, S. Pauschenwein, W. Waldha¨usl, K. Po¨lzler, P. Nowotny, and H. Vierhapper, “Increased prevalence of heterozygous 21-OH germline mutations in patients with adrenal incidentalomas,” Clinical Endocrinology, vol. 56, no. 6, pp. 811–816, 2002. [13] S. Jaresch, E. Kornely, H.-K. Kley, and R. Schlaghecke, “Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia,” The Journal of Clinical Endocrinology & Metabolism, vol. 74, no. 3, pp. 685– 689, 1992. [14] M. Kjellman, M. Holst, M. Backdahl, C. Larsson, L.-O. Farnebo, and A. Wedell, “No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours,” Clinical Endocrinology, vol. 50, no. 3, pp. 343–346, 1999. [15] A. Patocs, M. Toth, and C. Barta, “Hormonal evaluation and mutation screening for steroid 21-hydroxylase deﬁciency in patients with unilateral and bilateral adrenal incidentalomas,” European Journal of Endocrinology, vol. 147, no. 3, pp. 349– 355, 2002. Case Reports in Medicine [16] S. Pang, D. Becker, J. Cotelingam, et al., “Adrenocortical tumor in a patient with congenital adrenal hyperplasia due to 21- hydroxylase deﬁciency,” Pediatrics, vol. 68, no. 2, pp. 242–246, 1981. [17] H. Selye and H. Stone, “Hormonally induced transformation of adrenal into myeloid tissue,” American Journal of Pathology, vol. 26, pp. 211–233, 1950. [18] H. Hagiwara, T. Usui, T. Kimura, et al., “Lack of ACTH and androgen receptor expression in a giant adrenal myelolipoma associated with 21-hydroxylase deﬁciency,” Endocrine Pathol- ogy, vol. 19, no. 2, pp. 122–127, 2008. [19] R. M. Rajput, A. M. Bhansali, N. M. Khandelwal, and B. D. Radotra, “Evolution of adrenal myelolipoma in a patient with congenital adrenal hyperplasia,” Endocrinologist, vol. 17, no. 4, pp. 200–201, 2007. [20] R. Dell’Avanzato, F. Gastaldi, C. Giovanni, et al., “Giant symptomatic myelolipoma of the right adrenal gland: a case report,” Chirurgia Italiana, vol. 61, no. 2, pp. 231–236, 2009. [21] D. P. Merke, “Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deﬁciency,” The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 3, pp. 653– 660, 2008.